| Single-dose IV oritavancin was successfully used to expedite hospital discharge in hospitalized patients with skin and soft tissue infections (SSTIs) who were hemodynamically stable. |
| Patients who received single-dose IV oritavancin to expedite hospital discharge had shorter hospital length of stay, lower 30-day SSTI-related hospital readmission rates, and less SSTI progression relative to patients discharged on oral antibiotics. |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.